首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
admin
2013-11-29
124
问题
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolution is based on the idea that the sicker people are, the more freedom they should have to try drugs that are not yet fully tested. For fifty years government policy has been driven by another idea: the fear that insufficiently tested medicines could cause deaths and injuries. The urgent needs of people infected with HIV, the AIDS virus, and the possibility of meeting them with new drugs have created a compelling countervailing force to the continuing concern with safety. As a result, government rules and practices have begun to change. Each step is controversial. But the shift has already gone far beyond AIDS. New ways are emerging for very sick people to try some experimental drugs before they are marketed. People with the most serious forms of heart disease, cancer, emphysema, Alzheimer’ s or Parkinson’ s disease, multiple sclerosis, epilepsy, diabetes, or other grave illnesses can request such drugs through their doctors and are likelier to get them than they would have been four years ago. "We’ve been too rigid in not making lifesaving drugs available to people who otherwise face certain death," says Representative Henry Waxman, of California, who heads the subcommittee that considers changes in drug-approval policies. "It’s true of AIDS, but it’s also true of cancer and other life- threatening diseases."
For the first time, desperate patients have become a potent political force for making new medicines available quickly. People with AIDS and their advocates, younger and angrier than most heart-disease or cancer patients, are drawing on two decades of gay activists’ success in organizing to get what they want from politicians. At times they found themselves allied with Reagan Administration deregulators, scientists, industry representatives, FDA staff members, and sympathetic members of Congress. They organized their own clinical trials and searched out promising drugs here and abroad. The result is a familiar Washington story: a crisis—AIDS—helped crystallize an informal coalition for reform.
AIDS gave new power to old complaints. As early as the 1970s the drug industry and some independent authorities worried that the Food and Do, g Administration’ s testing requirements were so demanding that new drugs were being unreasonably delayed. Beginning in 1972, several studies indicated that the United States had lost its lead in marketing new medicines and that breakthrough drugs—those that show new promise in treating serious or life-threatening diseases— had come to be available much sooner in other countries. Two high-level commissions urged the early release of breakthrough drugs. So did the Carter Administration, but the legislation it pro- posed died in Congress. Complaints were compounded by growing concern that "if we didn’t streamline policies, red tape wot, Id be an obstacle to the development of the biotechnology revolution," as Frank E. Young, who was the head of the FDA from 1984 to 1989, put it in an interview with me.
Young was a key figure in the overhaul of the FDA’s policies. A pioneer in biotechnology and a former dean of the University of Rochester’s medical school, he came to Washington with an agenda and headed the agency for five and a half years—longer than anyone else has since the 1960s. Young took the FDA job to help introduce new medicines created by biotechnology-- whose promise he had seen in his own gene-cloning lab--and to get experimental medicines to desperately iii people more quickly. He had seen people die waiting for new medicines because "they were in the wrong place at the wrong time," he said. That is now changing.
From the second paragraph, we learn that ______.
选项
A、AIDS people tend to get angrier than all cancer patients
B、AIDS people have learned some experience from homosexual people in dealing with politicians
C、AIDS people have got some representatives in government organizations
D、AIDS people often work together with gay activists
答案
B
解析
转载请注明原文地址:https://kaotiyun.com/show/vHhO777K
0
考博英语
相关试题推荐
ThedomesticeconomyintheUnitedStatesexpandedinaremarkablyvigorousandsteadyfashion.Therevivalinconsumerconfiden
TheearlyretirementofexperiencedworkersisseriouslyharmingtheUSeconomy,accordingtoanewreportfromtheHudsonInsti
Variousinnovationshavebeenintroducedaswaystobreakoffoursystemwhichforcesstudentsthroughaseriesofidenticalcla
Youheartherefrainallthetime:theU.S.economylooksgoodstatistically,butitdoesn’tfedgood.Whydoesn’tever-greater
Youheartherefrainallthetime:theU.S.economylooksgoodstatistically,butitdoesn’tfedgood.Whydoesn’tever-greater
Whenitcomestotheslowingeconomy,EllenSpiroisn’tbitinghernailsjustyet.Butthe47-year-oldmanicuristisn’tcutting,
Inrecentyears,railroadshavebeencombiningwitheachother,mergingintosupersystems,causingheightenedconcernsaboutmo
Inrecentyears,railroadshavebeencombiningwitheachother,mergingintosupersystems,causingheightenedconcernsaboutmo
随机试题
中国革命必须走农村包围城市的道路,其主要依据是()
A.Osier结B.Ewart征C.肝脏扩张性搏动D.Duroziez氏血管杂音E.Beck三联征
患者,女,32岁,不慎外阴受伤,20分钟后出现外阴肿物,疼痛难忍,最可能的诊断是
下列哪项不是甘草的粉末特征( )。
在国际债券市场上,不需要官方主管机构批准,也不受货币发行国有关法令管制和约束的债券是()。
一般认为,金融工具具有流动性、风险性和收益性的特征。()
禁止与取缔,是指公安机关依法对某些犯罪行为和违反治安管理、扰乱社会秩序、妨害公共安全的行为宣布禁止,予以取缔,并对违禁者予以法律制裁。( )
自顶向下规划的重要目标是达到信息的一致性,即保证下列()的一致。Ⅰ.数字字段定义Ⅱ.数据结构Ⅲ.更新时间Ⅳ.更新规划Ⅴ.数据记录
将内部专用IP地址转换为外部公用IP地址的技术是()。
若有以下程序段intr=8;printf("%d\n",r>>1);输出结果是
最新回复
(
0
)